Lax, Cole will have nothing to do with increased revenue in q2 or q3,q4. You know that. But, the second part of your question, will more patients have CML cancer, the answer is unfortunately yes, and more patients will discover they have mutations as well as we move forward in time. I expect you knew that as well..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.